Skip to main content

Table 3 Genotypes frequencies in the studied group

From: The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients

ERCC1 C118T % (N) ERCC1 C8092A % (N) ERCC2 G312A % (N) ERCC2 A751C % (N)
CC 27.3 (12) CC 29.55 (13) GG 40.9 (18) AA 46.3 (19)
CT 54.5 (24) CA 65.91 (29) GA 52.3 (23) AC 48.8 (20)
TT 18.2 (8) AA 4.54 (2) AA 6.8 (3) CC 4.9 (2)
Total 44 Total 44 Total 44 Total 41